RAPT Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
RAPT Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2020 to Q2 2024.
  • RAPT Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $77.8M, a 49.8% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $77.8M -$77.1M -49.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $96.3M -$89.6M -48.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $111M -$98.7M -47% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $131M -$37.1M -22.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $155M +$4.7M +3.13% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $186M +$45.3M +32.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $210M +$44.5M +26.9% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $168M +$16.9M +11.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $150M +$13.1M +9.52% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $141M +$66.9M +90.8% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $166M +$79M +91.3% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $151M +$48.2M +47% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $137M +$33.1M +31.8% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $73.7M +$27M +57.9% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $86.6M Dec 31, 2020 10-K 2022-03-10
Q3 2020 $103M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $104M Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $46.7M Mar 31, 2020 10-Q 2020-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.